A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage  by Goshima, Kaoru Ruth et al.
From the American Association for Vascular Surgery
A new look at outcomes after infrainguinal bypass
surgery: Traditional reporting standards
systematically underestimate the expenditure of
effort required to attain limb salvage
Kaoru Ruth Goshima, MD, Joseph L. Mills, Sr, MD, and John D. Hughes, MD, Tucson, Ariz
Background: Graft patency, limb salvage, and mortality are the traditional means of assessing the outcome of infrainguinal
bypass surgery (IBS). However, these measures underestimate patient morbidity and fail to consider the entire spectrum
of treatment required to restore the patients to their premorbid state. The aim of this study was to quantify the efforts
required to achieve limb salvage by assessing three nontraditional outcomes: (1) index limb reoperation rate in 3 months,
(2) hospital readmission rate in the first 6 months after IBS, and (3) wound-healing time.
Methods: We retrospectively analyzed 318 IBSs performed at a single institution. Repeat operations for limb or
graft-related problems and readmissions within 6 months of the initial operation were recorded. When available,
wound-healing time was determined. Pertinent demographics and comorbidities were subjected to univariate and
multivariate analysis to determine risk factors for adverse outcomes.
Results: Seventy-two percent of patients underwent IBS for critical limb ischemia (CLI), and 84% had below-knee
popliteal or distal bypasses. Among those who underwent IBS for CLI, 48.9% of patients required at least one reoperation
within 3 months. Within 6 months, 49.3% of patients required hospital readmission. Time to heal exceeded 3 months in
54% of patients. After multivariate analysis, tissue loss and minority status were significant risk factors for reoperation
within 3 months. Tissue loss and renal failure increased the odds for readmission within 6 months. Diabetes was the sole
risk factor for prolonged wound healing.
Conclusions: IBS for limb salvage is often complicated by prolonged recovery and multiple reoperations and readmissions.
Traditional reporting standards for limb salvage operations need modification to reflect the true outcome of such
procedures. (J Vasc Surg 2004;39:330-5.)
Because of improvements in surgical technique and
perioperative care, an aggressive approach to limb salvage
for patients with critical limb ischemia (CLI) has been
widely adopted.1 The success of IBS traditionally has been
measured solely in terms of mortality, graft patency, and
limb salvage rates.2 However, these traditional measure-
ments underestimate patient morbidity and fail to consider
the entire spectrum of treatment that is required to restore
patients to their premorbid state.
This study was conducted to quantify the effort re-
quired to treat limb ischemia by assessing three nontradi-
tional outcome measures: index limb reoperation rate
within 3 months of IBS, hospital readmission rate in the
first 6 months after leg bypass, and wound-healing time.
We also attempted to identify, by analysis of multiple
preoperative patient factors and characteristics, those indi-
viduals who are at particularly high risk for adverse out-
comes.
METHODS
The study population consisted of all patients who
underwent IBS for peripheral arterial occlusive disease at
the University of Arizona from 1990 to 2002. Infrainguinal
bypass operations for traumatic injuries were excluded from
the study. We also excluded those patients who underwent
initial IBS elsewhere.
Data were obtained from retrospective review of med-
ical records. Demographic information, as well as pertinent
medical conditions such as diabetes mellitus, renal failure,
and cardiovascular disease, was recorded. Operative indica-
tions were categorized into claudication, rest pain, and
ischemic tissue loss. During the study period, IBS for
claudication was reserved for patients with significant life-
style limitation who had been refractory to nonoperative
treatment, including smoking cessation, exercise regimen,
and medical treatment. Therefore, the majority (72%) of
our IBS were performed for indication of CLI.
Of the 315 vascular reconstructions, 285 (91%) were
performed using autogenous venous conduits. These con-
duits included leg (greater or lesser saphenous) veins, arm
(basilic or cephalic) veins, or spliced vein conduits as re-
quired based on suitability and available length. Synthetic
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grafts were primarily employed in the femoral to above-
knee popliteal artery position, with the exception of a
modest number of cases in which PTFE with adjunctive
Taylor patch,3 PTFE Distaflo (Bard-Impra Inc, Tempe,
Ariz) grafts, or composite grafts were used for infragenicu-
late bypasses because of a lack of autogenous vein. There
were only 13 limbs that were bypassed with nonautogenous
grafts in patients with either minor or major tissue loss.
The patients with CLI, either rest pain or ischemic
tissue loss, were further analyzed to determine the nontra-
ditional outcomes. End points for each nontraditional out-
come were selected before data collection and review based
on our experience and are described in the following para-
graphs.
Early and intermediate reoperation was defined as any
operative procedure performed within 3 months of the
initial vascular reconstruction. Subsequent wound debride-
ments and minor amputations for infected or ischemic
lesions that required return to the operating room were also
included. However, those procedures performed at the
bedside or in clinic settings were excluded. Grossly infected
tissue was surgically debrided to control infection first.
After the revascularization, further debridements were per-
formed as necessary to obtain a healed foot. Such proce-
dures included redebridement alone; additional toe ampu-
tations; transmetatarsal amputation, Chopart, and Lisfranc
amputations; and even free flaps if needed to obtain a
healed foot or to cover large wound defects. Well-demar-
cated dry gangrenous toes were amputated and closed if
possible at the time of the index revascularization. If there
was not clear demarcation, we waited for at least 5 to 7 days
for the foot to declare itself before performing amputation
or debridements.
Early-intermediate hospital readmission was defined as
any admission within 6 months of the initial index IBS. The
number of readmissions and cumulative length of stay were
noted. We also determined and recorded whether any
readmission was related to the initial IBS itself or to asso-
ciated medical or nonvascular comorbidities.
We reviewed the office charts, when available, to assess
the course of wound healing. More than 50% of patients
had close follow-ups subsequent to their IBS, with clear
documentation of their wound-healing courses. Prolonged
wound healing was defined as a period exceeding 3 months
to achieve complete wound healing.
Data were then processed using the SPSS program
(SPSS Inc, Chicago, Ill). Descriptive statistics were used to
calculate relative risks or odds ratios (OR). Chi-square was
used to calculate P value to assess statistical significance
(P  .05 was considered significant). Multiple logistic
regression models with stepwise analysis were used to per-
form multivariate analysis. Cox regression survival analysis
was used to generate the time for wound-healing curves.
RESULTS
There were 318 IBS procedures meeting inclusion
criteria; initial inpatient charts were available for complete
review in 315 cases. Demographic data are summarized in
Table I. Approximately 72% of patients (n  229) under-
went IBS for CLI as defined by the presence of ischemic rest
pain or tissue loss. Infrageniculate bypass was required in
84% of patients, of whom 13% had popliteal artery as the
inflow source and 52% had tibial or pedal outflow targets.
The incidence of perioperative complications, reopera-
tion within 3 months, and readmission within 6 months
were calculated for the patients with claudication, rest pain,
and ischemic tissue loss. The results are summarized in Fig
1.
We focused our analysis on those patients with CLI.
Perioperative complications occurred in 19.2% of patients
with CLI. Perioperative wound complications were defined
as either ischemic or infectious wound problems that re-
quired operative management during the initial hospital
stay. Table II summarizes the incidence of specific compli-
cations. The median of the initial hospital length of stay was
9 (range, 3 to 92) days.
Intermediate postoperative outcomes and complica-
tions were also carefully evaluated and analyzed. Within 3
months of the initial IBS, 48.9% of patients underwent at
least one additional operation. The variety and scope of
operative procedures required during this intermediate
postoperative period are summarized in Table III. These
operations included free flaps to cover large wound defects,
Table I. Demographics
No. of
patients %
Age 75 y 104 33
Female 130 41
Caucasian 211 67
Hispanic 72 23
Native American 26 8
African American 6 2
Diabetes mellitus 154 49
Renal failure 53 17
Congestive heart failure 51 16
Coronary artery disease 141 44
Hyperlipidemia 80 25
Previous stroke 40 13
Previous smokers 122 38
Current smokers 87 27
Previous PVD
operations
90 28
Table II. Summary of specific perioperative
complications for CLI patients
Complications
No. of
patients %
Wound complications 26 11.4
Graft thrombosis 8 3.5
Myocardial infarction 9 3.9
Hemorrhage 3 1.3
Stroke 3 1.3
Death 3 1.3
Others 10 5.7
Total 44 19.2
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ligation of AV fistulae after in situ bypass, graft revision
procedures for stenosis, amputations and debridements,
contralateral limb procedures, and unrelated operations.
The overall hospital readmission rate for the CLI pa-
tients within 6 months of the original index revasculariza-
tion was 49.3%. The cumulative median length of stay for
all readmissions was 11 days. Approximately two thirds of
all readmissions were directly attributable to issues related
to infection or nonhealing of the foot among CLI patients.
Table IV summarizes reasons for hospital readmission,
comparing the CLI patients and claudicants. The majority
of IBS-related admissions for claudicants was due to graft
stenosis or thrombosis.
Using SPSS statistical software, numerous pertinent
preoperative characteristics summarized in Table I were
examined to determine the respective odds ratios (OR) for
the development of the perioperative complications and
adverse nontraditional outcomes. The results are detailed in
Figs 2 to 5 (online only).
A history of congestive heart failure, hyperlipidemia,
and CAD all increased the risk of perioperative complica-
tions by nearly two-fold in univariate analysis. After multi-
variate analysis, however, only CAD was found to be statis-
tically significant, with OR of 2.35 and P value of .014.
Advanced age, gender, diabetes, renal failure, and previous
leg bypass were not associated with an increased risk for
perioperative complications.
Univariate analysis revealed that operations for isch-
emic tissue loss (OR 3.5), minority status (OR 2.6), renal
failure (OR 2.5), and diabetes mellitus (OR 1.9) were
associated with significantly increased risk for reoperation
in the intermediate postoperative period. After multivariate
analysis, however, only tissue loss and minority status were
statistically significant (OR 3.1 and 2.2; P values, .001 and
.007, respectively).
Ischemic tissue loss (OR 2.9), renal failure (OR 2.8),
and diabetes mellitus (OR 2.3) were also the leading risk
Fig 1. Incidence of perioperative complications, reoperations, and readmissions.
Table III. Reoperation by 3 months
Procedure
No. of
patients %
Minor amputation 51 22.3
Debridement of ischemic
wounds
36 15.7
Skin grafting 21 9.2
Bypass graft revision 19 8.3
Surgical wound management 19 8.3
Major amputation 8 3.5
Redo bypass graft 4 1.7
Other 30 13.1
Total 112 48.9
Table IV. Factors leading to readmissions
Reasons for
readmissions CLI patients Claudicants
Related to the initial IBS 136 13
Contralateral limb
problem
18 7
Cardiac issues 17 4
Pneumonia 9 0
Renal failure and fistula
complications
8 0
Sepsis 7 0
Pulmonary embolus 2 0
Gastrointestinal problems 4 1
Hypoglycemia 2 0
Syncope 1 1
Stroke 1 0
Unrelated operations 4 3
Total admissions 209 29
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factors for readmission within 6 months in the univariate
analysis. Minority status increased the risk for the reop-
eration within 3 months, but not for readmission within
6 months. After multivariate analysis, tissue loss and
renal failure were found to be significant risk factors,
with OR of 2.8 and 2.3 (P values .004 and .021, respec-
tively).
Among the CLI patients, 76% (174) of patients under-
went arterial bypass for ischemic tissue loss. Of this patient
cohort, 137 office charts were available to assess the long-
term follow-up with respect to wound healing. There were
17 patients who never healed the wound during the fol-
low-up period, and 13 limbs required major amputations
(below-knee or above-knee amputations). Only 63 patients
(46%) required 3 months to achieve complete wound
healing. The median wound-healing time was 86 days. The
risk factors associated with prolonged wound-healing time
were diabetes mellitus and hypertension, based on the
univariate analysis. After multivariate analysis, only diabetes
was associated with prolonged wound healing (OR 3.42, P
value .003). Cox regression survival analysis was used to
analyze the wound healing time for diabetic and nondia-
betic patients (Fig 6).Table V summarizes the significant
risk factors for adverse outcomes identified by multivariate
analysis.
DISCUSSION
The outcomes of IBS traditionally have been reported
and assessed in terms of graft patency, limb salvage, and
patient survival rates. In the present study, perioperative
mortality was 0.9%, and 30-day graft thrombosis rate was
3.1%. In our previously published series, the 5-year limb
salvage rate was 91%, and the 5-year assisted-primary graft
patency rate was 72%.4 Cost analysis revealed that limb
salvage–related expenses over 5 years, including those gen-
erated by graft surveillance and maintenance (revisions)
were equivalent to the cost of primary major limb amputa-
tion.4 However, these traditional measures and financial
analyses inaccurately depict the true scenario for a patient
Fig 6. Wound healing curves.
Table V. Multivariate analysis: risk factors for adverse
outcomes
Outcomes Risk factors
Odds
ratios
Reoperation  3 mo Ischemic tissue loss 3.1
Minority status 2.2
Readmission  6 mo Ischemic tissue loss 2.8
Renal failure 2.3
Delayed wound
healing
Diabetes mellitus 3.4
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with CLI requiring revascularization (IBS). We believe that
these traditional reporting standards systematically under-
estimate the expenditure of effort and associated patient
morbidity that are involved in the management of CLI
patients.
Recently, functional outcome assessments of IBS have
been published by Abou-Zamzam et al5 from the Oregon
group. Those investigators assessed the preoperative and
postoperative ambulation status and independence of pa-
tients. They concluded that preoperative independence and
ambulation were the best predictors of postoperative inde-
pendence and continued ambulation.
Patient recovery after IBS for limb salvage has been
reported by Nicoloff et al,6 also based upon the Oregon
experience. That group emphasized that an ideal outcome,
as defined by the expectations of a patent graft, healed
wound, no need for reoperation, independent living status,
and continued ambulation was extremely difficult to
achieve in such patients. Only a small fraction (25%) of
their patients met these basic criteria.6
There is a paucity of reliable information in the vascular
surgical literature that realistically depicts the typical course
that a CLI patient actually faces in the early and intermedi-
ate postoperative period once one embarks on the uphill
and difficult path of limb salvage. In this study, we at-
tempted to accurately define the expenditure of effort and
the complications and difficulties encountered by the pa-
tient and the surgical team to achieve limb salvage in the
early and intermediate postoperative period. We analyzed
in some detail three specific, nontraditional outcomes mea-
sures: (1) reoperation within 3 months, (2) readmission in
the first 6 months after the index revascularization opera-
tion, and (3) time to complete wound healing.
At least one reoperation was required in 48.9% of
patients for limb- and graft-related problems within 3
months of the index revascularization. The dominant risk
factor for reoperation was the presence of ischemic tissue
loss. The majority of such patients require minor proce-
dures related to their initial ischemic wounds, such as
debridements and minor amputations.
Hospital readmissions within 6 months were required
in 49.3% of patients. By multivariate analysis, ischemic
tissue loss and renal failure increased the likelihood of
readmission. Although two thirds of these readmissions
were specifically due to issues relating to their ischemic
limb, it is worth noting that the remaining one third
resulted from complications arising from associated medi-
cal comorbidities. This confirms the significance of comor-
bidities in patients with CLI that require ongoing care.
Less than half of those patients presenting with isch-
emic tissue loss achieved complete wound healing within a
3-month period. In this study, diabetes proved to be the
dominant risk factor for the prolonged wound healing. The
pathophysiologic relationship between diabetes and im-
paired wound healing is complex. Vascular, neuropathic,
immunogenic, and biochemical abnormalities all contrib-
ute to a diminished capacity for tissue repair.7 Diabetic
patients, particularly those with renal failure, often suffer
nonhealing wounds despite patent, functional bypass
grafts.
Numerous publications have suggested that the pres-
ence of renal failure interferes with wound healing. In a
study published by Johnson et al8 from South Florida,
failure of foot salvage in renal failure patients was related to
poor wound healing, such as ongoing ischemia or uncon-
trollable infection, despite a functional graft. These patients
may ultimately require major limb amputation despite on-
going graft patency.9 In the present report, although renal
failure was a major risk factor for repeat operation and
readmissions, it was not a major risk factor for prolonged
wound healing.
Coronary artery disease was the leading risk factor for
perioperative complications. Increased perioperative mor-
bidity and mortality for patients with preexisting cardiac
disease has been reported elsewhere.10 A recent publication
confirms poorer outcomes for patients taking furosemide
preoperatively.11 By univariate analysis, congestive heart
failure was one of the risk factors for increased perioperative
complications; however, it failed to remain as a statistically
significant risk factor after multivariate analysis.
Our perioperative wound complication (11%) is signif-
icantly less than the 40% rate published elsewhere.12 This is
because we only included wound complications that re-
quired surgical management in the operating room. Minor
wound issues managed in outpatient clinic with simple
debridement and dressing changes were not considered
major wound complications.
We were unable to include in this study a quantification
of the time that was expended in the care of ischemic and
infected wounds and the number of outpatient office visits
that were needed to provide ongoing outpatient wound
management. In addition, most patients undergoing IBS
for limb-threatening ischemia are nearing the end of life.
The previously reported 5-year survival rate for CLI pa-
tients has ranged from 12% to 64%, with a mean of 45% to
50%.6 Therefore, many of these patients spend a significant
portion of their remaining life attending to their ischemic
limb needs. It is thus important to assess quality of life issues
for CLI patients to provide them optimal care.
CONCLUSIONS
This study, of course, is limited by its retrospective
nature and consists of high-risk patients who were referred
to a tertiary care center with an interest and experience in
CLI. However, by analyzing three nontraditional outcome
measures, we believe that the effort required to achieve
limb salvage has been quantified in a more scientific man-
ner. To achieve limb salvage, ongoing and extensive med-
ical and surgical interventions must be continued for a
prolonged interval after the initial operation. Even within
the early to intermediate postoperative convalescent pe-
riod, patients should be informed that multiple operations
and readmissions are commonplace, are to be expected, and
are, in fact, the norm. For some of these individuals, the
option of major limb amputation, rather than limb salvage,
needs to be at least considered and carefully discussed,
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given the anticipated prolonged recovery. This information
may be of clinical utility when counseling CLI patients by
providing a more realistic picture of what a patient may
expect to encounter once the path for the limb salvage is
chosen. At the same time, the traditional reporting stan-
dards for limb salvage operations need modification to
reflect the true outcome of such procedures.
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DISCUSSION
Dr Gregorio A. Sicard (St. Louis, Mo). Of the patients who
had more than 3 months, or 3 months or longer, for wounds
healing, for how many of those was the reoperation an amputation?
In other words, could you predict, based on the time that it would
take to heal, which one of those would lead to an amputation
rather than reoperation or skin grafting, etc?
Dr. Joseph L. Mills, Sr. We didn’t focus on that, but very few
of the reoperations were major limb amputations. Our amputation
rate for the first 6 months was between 3% and 5%. So it’s very low.
But we had some patients whose wounds never healed. There were
actually, I think, 8 or 10 individuals who either died with patent
graft or lived in a wheelchair the rest of their life and didn’t heal
their wounds at all. And then we had a couple who just chronically
came back to clinic with a tiny ulcer that we could never get to heal
and the patients were extremely frail, so we let them live with their
nonhealing ulcers.
But what we tried to focus on in this paper was not so much
limb amputation rate, but something, I think, that’s been ne-
glected, and that is what these patients go through as we try to get
them to the point where they heal. And we started to wonder in
some patients if it’s worth it if they have 2 years of life left and you
spend a year trying to get this ulcer to finally heal. Is that effort cost
effective?
Dr Mark R. Nehler (Denver, Colo). How did you stratify the
tissue loss in the patients with Fontaine IV—what was minor and
what was major? Does this have a big impact on the outcomes and
recurrent surgeries?
Dr. Mills. I think it does. One particular group that we’ve
noted trouble with is heel ischemia in renal failure patients. So if a
patient had significant heel ischemia, that was considered major
tissue loss. Minor was an ulcer or just gangrene of the tip of the toe.
If the gangrene involved the forefoot or three toes or more, that
was considered major.
Dr Frank J. Veith (Bronx, NY). This is a very nice paper, and
you have documented very clearly something we have known now
for 20-plus years, that this is a difficult business. It is not simple to
save limbs that have established gangrene.
The implication that you have made in the presentation was
that there are some patients who should have a primary amputa-
tion. And we have looked at this very hard and very long over the
years and have not been able to come up with a criterion, other
than perhaps extensive gangrene in the presence of renal failure.
But all other factors seem not to preclude limb salvage. So I
wonder if you have found criteria by which you could say: yes, we
should do a primary amputation.
We do tell our patients just what you tell them, namely, this is
not a simple business, but we still think it is worthwhile. And of
course, cost issues and DRG length-of-stay issues as we presented
yesterday are still very important in this area.
I wonder how you respond to these comments?
Dr Mills. I think our practice is much like yours. We’re still
trying to search for some algorithm that will tell us which patient
really should have an amputation. But if you look at the quality of
life in many of these individuals, if they have an amputation, it’s
even worse.
So I think that in most of these patients it is worth this process.
But I think you need to tell them up front what lies ahead. Our
finding that struck us was that, in every one of those nontraditional
outcomes that we looked at, congestive heart failures was one of
the risk factors for reoperation, perioperative complication and
readmission within 6 months. And that implies to me that maybe
it’s limb edema or perhaps even low cardiac output that prohibits
wound healing, but maybe we could do a better job targeting those
patients. Obviously, we don’t take someone to the operating room
with uncontrolled congestive heart failure, but maybe these people
deserve a little bit of extra attention to try to get them to heal. But
we have not yet been able to develop more specific criteria to
predict those patients who would be best served by primary ampu-
tation because those patients also do quite poorly and there are lots
of studies that show that.
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